SO
MACK

STRS Ohio’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

STRS Ohio’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,000
Closed -$280K – 2145
2024
Q1 		$280K Buy
19,000
+15,700
+476% +$221K ﹤0.01% 1464
2023
Q4 		$44K Buy
+3,300
New +$41.7K ﹤0.01% 1794
2017
Q4 		– Sell
-4,703
Closed -$53K – 1992
2017
Q3 		$53K Buy
+4,703
New +$49.4K ﹤0.01% 1780

Other funds holding MACK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

STRS Ohio's MACK Position: Q2 2024 in Review

STRS Ohio sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 19,000 shares — an estimated $280K sold.

STRS Ohio first reported a position in MACK in Q3 2017 and held it in 3 quarters. The position peaked at $280K in Q1 2024. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

  • STRS Ohio reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 19,000 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $280K.
  • STRS Ohio first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
  • STRS Ohio's Merrimack Pharmaceuticals, Inc. position peaked at $280K in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.